Cell-based Influenza (H2N3) Vaccine (Seqirus )

N/A

Report date: 2024/09/23 16:32:22

Base Information

Drug NameCell-based Influenza (H2N3) Vaccine (Seqirus )
Drug Alias NameSQ-009
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsVirus DiseasesInfluenza, HumanRespiratory Tract Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPhilippines
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSeqirus
China Registration ClassN/A

Develop Information

Active CompaniesSeqirus
Inactive CompaniesN/A
Active IndicationsVirus DiseasesInfluenza, HumanRespiratory Tract Infections
Inactive IndicationsInfections

Other Information

ATC CodeN/A
Related LinksN/A